Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market Research Report – Segmented By Technology (Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests (RDTs), and Others); By End-User (Hospitals, Clinics, Maternity Centres and Homecare); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

 

Chapter 1. Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market– Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sour
1.5    Secondary Sources
Chapter 2. Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market– Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
          2.3.1    Impact during 2023 – 2030
          2.3.2    Impact on Supply – Demand
Chapter 3. Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market– Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
          4.4.1     Bargaining Power of Suppliers
          4.4.2     Bargaining Powers of Customers
          4.4.3    Threat of New Entrants
          4.4.4    .Rivalry among Existing Players
          4.4.5    Threat of Substitutes
Chapter 5.Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
Chapter 6.Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market- By Technology
6.1    Nucleic Acid Amplification Tests (NAATs)
6.2    Rapid Diagnostic Tests (RDTs)
6.3    Others
Chapter 7.Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market- By End-User
7.1    Hospitals
7.2    Maternity Centres
7.3    Clinics
7.4    Homecare
Chapter 8. Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market– By Region
8.1    North America
8.2    Europe
8.3    Asia-Pacific
8.4    Latin America
8.5    The Middle East
8.6    Africa
Chapter 9. Global Point-of-Care Diagnostics for Maternal and Neonatal Health Market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1    Abbott Laboratories
9.2    Roche
9.3    Siemens Healthineers
9.4    PerkinElmer
9.5    Sysmex Corporation

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800

Frequently Asked Questions

The current trend in the Global Point-of-Care Diagnostics for Maternal and Neonatal Health market is the increasing adoption of innovative and portable diagnostic technologies.

Asia Pacific region is experiencing the highest growth rate in the market

The key technologies used in point-of-care diagnostics for maternal and neonatal health include Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests (RDTs), and other

The main challenges faced by the market in improving healthcare outcomes for mothers and newborns include inadequate access to healthcare facilities and limited resources in remote areas.

The key opportunities for growth and development in the Global Point-of-Care Diagnostics for Maternal and Neonatal Health market include increasing demand for convenient healthcare services and advancements in diagnostic technologies